Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
暂无分享,去创建一个
Nandita Mitra | Jarod Finlay | Eli Glatstein | Stephen Hahn | Lilie Lin | S. Hahn | C. Langer | N. Mitra | R. Rengan | E. Glatstein | J. Stevenson | Annemarie T Fernandes | Jason Shen | Tracey Evans | James Stevenson | Corey Langer | Ramesh Rengan | J. Finlay | T. Evans | Lilie L. Lin | A. Fernandes | Jason Shen
[1] A. Cameron,et al. Radiosensitivity in ataxia-telangiectasia. , 1975, The British journal of radiology.
[2] D. Owens,et al. Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with NonSmall-Cell Lung Cancer , 2003, Annals of Internal Medicine.
[3] R. T. Ten Haken,et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.
[4] J. Lebesque,et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[5] D. Heitjan,et al. Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study , 2007, Statistics in medicine.
[6] E. Yorke,et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. L. Morgan,et al. Radiation reaction in ataxia telangiectasia. , 1968, American journal of diseases of children.
[8] Jinming Yu,et al. A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer , 2007, American journal of clinical oncology.
[9] S Kramer,et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non‐oat‐cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group , 1980, Cancer.
[10] C. Ling,et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[11] R. Kronmal,et al. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. , 1998, Biometrics.
[12] R. V. van Klaveren,et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[13] G. Watanabe,et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. , 2001, The Annals of thoracic surgery.
[14] S. Novello,et al. Use of chemo-radiotherapy in locally advanced non-small cell lung cancer. , 2002, European journal of cancer.
[15] J. Daurès,et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] R. Arriagada,et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.
[17] Di Yan,et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.
[18] Brady T. West,et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[19] K. Bujko,et al. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques – A retrospective analysis , 2008, Acta oncologica.
[20] W. Richards,et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. , 2000, The Annals of thoracic surgery.
[21] W. Hong,et al. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer. , 2009, International journal of radiation oncology, biology, physics.
[22] U. Pastorino,et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. , 1999, The Journal of thoracic and cardiovascular surgery.
[23] M. Parmar,et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial , 1997, The Lancet.
[24] S. Piantadosi,et al. Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881. , 1994, Chest.
[25] B. Neyns,et al. Final Overall Results of a Study with a Novel Triplet Induction Chemotherapy Regimen (PACCAGE) Followed by Consolidation Radiotherapy in Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC) , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.